The non-recognition of the Sputnik V vaccine in WHO is explained: Society: Russia: Lenta.ru
Head of Russian Direct Investment (RDIF) Kirill Dmitriev in an interview for the newspaper La Nacion explained the delay in the approval of the Russian coronavirus vaccine “Sputnik V” by the World Health Organization (WHO) bureaucratic drugs obstacles.
According to Dmitriev, Moscow does not see any particular reason why WHO is delaying its effectiveness in recognizing the vaccine, since Sputnik V has been confirmed not only by publications in authoritative medical journals, but also by real data from around the world. He also noted that after approval of the drug, vaccinations will allow Russians to enter even more countries.
In November, Kirill Dmitriev said that the question of WHO’s recognition of “Sputnik V” would be resolved “literally in the near future.” He explained that the remaining bureaucratic stages will be passed in the next few months. Prior to that, Dmitriev stated that he approved the vaccine until the end of 2021.
The EUL preconditions required for an EUL assessment are a prerequisite for all applicants. “
In addition to on the road to drug recognition, the Russian side must provide updated information on “corrective and preventive measures (CAPA)”. As soon as the application and all materials are received and considered, “the applicant will be given a decision on the need for an on-site verification inspection,” added the WHO.
Russian Foreign Minister Sergei Lavrov said in November that Russian specialized structures are working with the European Medicines Agency (EMA) on the recognition of the Russian vaccine. According to him, the decision to recognize vaccination with the drug is being delayed, but the topic is under control.
The German Embassy, when asked about the recognition of “Sputnik V”, replied that it is necessary to carry out the equivalence of the drug with the vaccines approved by the EMA. Italian Ambassador to Russia Giorgio Starace said that his country does not recognize the Russian vaccine, bypassing the decision of the European Union. At the same time, he promised that Rome would contribute to a positive solution to this issue. He noted that Italy is interested in the acceleration of the Sputnik V recognition process.
The British Embassy in Moscow says that the approval of “Sputnik V” would be a positive step on the part of WHO, could contribute to the adoption of the drug around the world.
Hungarian Foreign Minister Peter Siyjarto called the issue of recognition of “Sputnik V” in Europe as political and ideological and accused European politicians of hypocrisy regarding the drug. He noted that every time they meet, European politicians say that the Russian vaccine is working well. “But despite all these words, spoken in person, in public, they behave completely differently.”
In response to a question about the recognition of the drug by the European European Politicians, they are immune to the pressure of European politicians. In his opinion, the calls of the politicians of the EU member states not to recognize the Russian vaccines do not affect the final decision of the EMA.
At the same time, Ederer notes that the Russian side allegedly itself is postponing the timing of the inspection requested by the EMA, and this is what slows down the process. Ederer, that such a delay is a matter of technology, not politics.
Speaking about the United States, the president of the American University in Moscow, political scientist Eduard Lozansky, said that there is a political issue of vaccination and a bias towards the Russian vaccine. He explained this by the fact that pharmaceutical giants are behind this, as it is unprofitable for them to appear on the American market of foreign competitors, including Sputnik V.
Back in September, the head of the Ministry of Health, Mikhail Murashko, said that the ministers of health of the G20 countries had named the Russian drug for coronavirus Sputnik V a vaccine in the world. He admitted that this is perhaps the first breakthrough in medical science, when a drug is known all over the world.
The effectiveness of the drug is evidenced by the results of its use. So, in San Marino, all San Marino vaccinated with the Russian vaccine have antibodies. The country’s health minister, Roberto Ciavatta, managed to keep the incidence rate at bay only after Sputnik V was brought into the country. The vaccine also showed the best protective efficacy against deaths in Hungary, where, in addition to it, four other vaccines are used.
Currently “Sputnik V” is registered in 70 countries, the total population of which is about four billion people. The drug is manufactured by more than 20 companies in 14 countries around the world. In Russia, the vaccine efficiency of the Gamaleya Center was 97.6 percent. The drug was 83.1 percent effective against the delta strain.